[Protective effect of adrenergic alpha blockaders on posthistamine bronchial spasm].
D000317:Adrenergic alpha-Antagonists / Q000627:therapeutic use*; D000328:Adult; D000420:Albuterol / Q000627:therapeutic use; D001249:Asthma / Q000188:drug therapy; D001985:Bronchial Provocation Tests / Q000379:methods; D001986:Bronchial Spasm / Q000188:drug therapy*; D004341:Drug Evaluation; D005260:Female; D005541:Forced Expiratory Volume; D006632:Histamine; D006801:Humans; D008297:Male; D010313:Partial Pressure; D010646:Phentolamine / Q000627:therapeutic use; D014797:Vital Capacity
D000317:Adrenergic alpha-Antagonists; D006632:Histamine; D000420:Albuterol; D010646:Phentolamine
Ochronny wpływ blokerów alfa-adrenergicznych na pohistaminowy skurcz oskrzeli.